Isomorphic Labs raises $2.1B Series B led by Thrive and Alphabet

Demis Hassabis' drug-discovery company raised $2.1B on May 12 from Thrive Capital, Alphabet, GV, MGX, Temasek, CapitalG and the UK Sovereign AI Fund to push AlphaFold-derived programs into the clinic.